Fentanyl Citrate
Pricing Report NDC 55253-072-30

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Fentanyl Citrate (NDC 55253-072-30) is $11.85350 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Apr 22, 2015.

As a provided by Cima Labs Inc., this medication is distributed in a 30 BLISTER PACK in 1 CARTON / 1 LOZENGE in 1 BLISTER PACK (55253-072-01) configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$11.85350
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Apr 22, 2015
Billable Units
30 EA
Estimated Package Price
$355.60
Data Status
As of May 11, 2016
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
55253-072-30
Description
30 BLISTER PACK in 1 CARTON / 1 LOZENGE in 1 BLISTER PACK (55253-072-01)
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Apr 2013, the NADAC wholesale price for (NDC ) has moved within a range of $10.78267 to $14.49673 per EA. Over this 2 years period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$10.7827 - $14.4967
Market Volatility
34.44% Variance
Latest Trend
10.75%
Date Unit Price Unit Source Method Rate
Apr 22, 2015 $11.85350 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 22, 2015 $11.85350 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Nov 19, 2014 $13.28156 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 19, 2014 $13.28156 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
May 21, 2014 $10.78267 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2014 $10.78267 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Mar 19, 2014 $11.52667 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2014 $11.52667 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Jan 22, 2014 $14.49673 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2014 $14.49673 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Apr 18, 2013 $10.92622 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026